-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

613. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster II

Symposia: Acute Myeloid Leukemias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Wenting Hu, MD1*, Zhuo Wang2*, Changcheng Chen, MD2* and Shuhong Shen, MD, PhD2

1Key Laboratory of Pediatric Hematology & Oncology of the Ministry of Health of China, Department of Hematology & Oncology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
2Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Shenghuan Sun1*, Jacob Cleave2*, Linlin Wang3*, Fabienne Lucas4*, Laura Brown5*, Jacob Spector6*, Leonardo Boiocchi2*, Jeeyeon Baik, BA, MPH7*, Menglei Zhu2*, Orly Ardon2*, Chuanyi M. Lu, MD, PhD8, Ahmet Dogan, MD, PhD7, Dmitry Goldgof9*, Iain Carmichael10*, Sonam Prakash5*, Atul Butte5* and Gregory Mark Goldgof11*

1University of California, San Francisco, San Francisco, CA
2Memorial Sloan Kettering Cancer Center, New York, NY
3UCSF, San Francisco
4Harvard Medical School, Boston
5University of California, San Francisco, San Francisco
6Boston Children's Hospital, Boston, MA
7Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY
8United States Department of Veterans Affairs, San Francisco, CA
9University of South Florida, Tampa, FL
10University of California, Berkeley, Berkeley, CA
11Memorial Sloan Kettering Cancer Center, Yew York

Vincent Marmouset, MD1*, Berengere Gruson, MD2*, Veronique Harrivel, MD3*, Céline Berthon, MD4*, Nicolas Duployez, MD5*, Claude Preudhomme, PharmD, PhD6*, Jean Pierre Marolleau, MD, PhD7, Pierre Morel, MD7*, Carine Hauspie, MD5*, Stéphane Morisset, Biostat8* and Delphine Lebon9*

1Hematology Department, Centre hospitalier universitaire d'Amiens, Amiens, AL, France
2Clinique de l'Europe, Amiens, FRA
3Hematology Laboratory, Centre hospitalier universitaire d'Amiens, Amiens, FRA
4Hematology Department, CHRU Lille, Lille, France
5Hematology Laboratory, CHRU Lille, Lille, France
6Hematology Laboratory, CHU Lille, Lille, France
7Service d’Hématologie Clinique, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France
8Centre Léon Bérard, Lyon, France
9Hematology Department, CHU Amiens, Amiens, France

Hisashi Ishida, MD1, Yuta Kawahara, MD, PhD2*, Daisuke Tomizawa, MD, PhD3, Yasuhiro Okamoto, MD, PhD4, Yuko Cho, MD, PhD5*, Katsuyoshi Koh6*, Yuhki Koga, MD, PhD7*, Asahito Hama8*, Maho Sato, MD, PhD9*, Kiminori Terui, MD, PhD10*, Naoyuki Miyagawa, MD, PhD11*, Akihiro Watanabe, MD, PhD12*, Junko Takita, MD, PhD13*, Koji Kato, MD, PhD14*, Kimikazu Matsumoto, MD, PhD15*, Moeko Hino, MD, PhD16*, Ken Tabuchi, MD, PhD17* and Hirotoshi Sakaguchi, MD, PhD15*

1Department of Pediatrics, Okayama University Hospital, Okayama, Japan
2Jichi Medical University School of Medicine, Shimotsuke, Japan
3Division of Leukemia and Lymphoma, Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan
4Kagoshima University, Kagoshima, JPN
5Hokkaido University Hospital, Sapporo, Japan
6Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan
7Graduate School of Medical Sciences, Kyushu University, Fukuoka, JPN
8Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Aichi Medical Center Nagoya First Hospital, Nagoya, JPN
9Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Izumi, JPN
10Hirosaki University School of Medicine, Hirosaki, JPN
11Kanagawa Children's Medical Center, Yokohama, JPN
12Niigata Cancer Center Hospital, Niigata, JPN
13Department of Pediatrics, Graduate School of Medicine Kyoto University, Kyoto, JPN
14Central Japan Cord Blood Bank, Seto, JPN
15National Center for Child Health and Development, Tokyo, Japan
16School of Medicine, Chiba University, Chiba, Japan
17Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan

Michelle Y. Zhang, MD1*, Carole Shaw2*, Kathryn Russell, ARNP1,2*, Rutu D. Vyas, CRA2*, Anna B. Halpern, MD1,2, Jacob S. Appelbaum, MD, PhD1,2, Cristina Maria Ghiuzeli, MD1,2, Roland B. Walter, MD, PhD, MS1,3,4 and Mary-Elizabeth M. Percival, MD1,2

1University of Washington, Seattle, WA
2Fred Hutchinson Cancer Center, Seattle, WA
3Translational Science and Therapeutics Division, Fred Hutchinson Cancer Research Center, Seattle, WA
4Division of Hematology, Department of Medicine, University of Washington, Seattle, WA

Philip A Haddad, MD1 and Suma Sri Chennapragada, MD2

1Feist-Weiller Cancer Center, LSUHSC-S/Overton Brooks VAMC, Shreveport, LA
2LSUHSC-S/Feist-Weiller Cancer Center, Shreveport, LA

Hanhua Liu, PhD1*, Simon J Stanworth, MD, DPhil2,3,4*, Sean McMphail1*, Mark Bishton, MD, PhD5, Brian Rous1*, Andrew Bacon1* and Thomas Coats, MBBS, PhD, FRCPath6*

1National Disease Registration Service, NHS England, Leeds, United Kingdom
2Oxford University Hospitals NHS Trust, Oxford, United Kingdom
3NIHR Blood and Transplant Research Unit in data driven transfusion practice, Oxford, United Kingdom
4NHS Blood and Transplant, Oxford, United Kingdom
5Translational Medical Sciences, University of Nottingham, Nothingham, United Kingdom
6Royal Devon & Exeter NHS Foundation Trust Wonford Site, Exeter, United Kingdom

Xia Bi, MD1*, Zoe Begun2*, Dolores A. Grosso1, Margaret Kasner, MD3, Gina Keiffer, MD3, Joanne Filicko-O'Hara, MD4, William O'Hara, PharmD5, John L. Wagner, MD1, Lindsay Wilde, MD6, Neal Flomenberg, MD1, Zixuan Wang7* and Usama Gergis, MD, MBA8*

1Bone Marrow Transplant and Cellular Therapy, Thomas Jefferson University Hospital, Philadelphia, PA
2Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA
3Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Jefferson Health, Philadelphia, PA
4Bone Marrow Transplant and Cellular Therapy, Sidney Kimmel Cancer Center of Thomas Jefferson University, Philadelphia, PA
5Department of Pharmacology, Thomas Jefferson University Hospital, Philadelphia, PA
6Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center, Jefferson Health, Philadelphia, PA
7Department of Pathology, Thomas Jefferson University Hospital, Philadelphia, PA
8Thomas Jefferson University, Philadelphia, PA

Guillaume Berton1*, Bochra Sedaki2*, Erwann Collomb3*, Sami Benachour, MD2*, Michael Loschi, MD, PhD4*, Bilal Mohty, MD5*, Colombe Saillard, MD5*, Yosr Hicheri5*, Camille Rouzaud, MD5*, Valerio Maisano, MD6*, Ferdinand Villetard, MD7*, Evelyne D'Incan Corda, MD7*, Aude Charbonnier, MD, PhD5*, Jerome Rey, MD5*, Marie Anne Hospital7*, Antoine Ittel, PharmD8*, Norman Abbou9*, Raphaelle Fanciullino10*, Bérengère Dadone-Montaudié11*, Norbert Vey, MD12, Geoffroy Venton, MD, PhD13*, Thomas Cluzeau, MD, PhD14, Anne Sophie Alary15* and Sylvain Garciaz12*

1Hematology Department, Institut Paoli-Calmettes, Marseille, AL, France
2Hematology Department, Nice University Hospital, Cote d’Azur University, Nice, France
3Hematology and Cellular Therapy Department, La Conception University Hospital, Marseille, France
4Centre Hospitalier Universitaire de Nice, Nice, France
5Department of Hematology, Institut Paoli-Calmettes, Marseille, France
6Hematology Department, Institut Paoli-Calmettes, Marseille, FRA
7Hematology Department, Institut Paoli-Calmettes, Marseille, France
8Department of Molecular Biology, Institut Paoli-Calmettes, Marseille, France
9CHU Nord, Marseille, France
10Aix Marseille Univ, Marseille, FRA
11Department of Pathology and Molecular Oncology, Molecular Oncology Unit, Nice University Hospital, Nice, France
12Aix-Marseille University, INSERM U1068, CNRS, Institut Paoli-Calmettes, CRCM, Marseille, France
13University Hospital Center of Marseille, Marseille, France
14Nice University Hospital, Nice, Provence Alpes Cote d'Azur, France
15Department of Biopathology, Institut Paoli-Calmettes, Marseille, France

Erlie Jiang, PhD1 and Mingyang Wang2*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
2National Key Laboratory of Blood Science, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China

Lili PAN, MD, PhD1,2*, Shenglong Lin, MD3*, Yi Zheng, MD1*, Yixin Ma2*, Yining Li2*, Yuwei Xie2*, Yuanhua Cai, MD, PhD1,2*, Xiaofan Li, MD, PhD1,2 and Shaoyuan Wang, MD1,2*

1Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, China
2Union Clinical Medical Colleges, Fujian Medical University, Fuzhou, China
3Department of Severe Hepatopathy, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China

Corentin Orvain1*, Anne Bouvier2*, Audrey Bidet, MD3*, Pierre-Yves Dumas, MD, PhD4*, Sarah Bertoli5*, Odile Blanchet6*, Sylvain Thepot, MD7*, Aline Schmidt, MD8*, Arnaud Pigneux, MD, PhD4*, Eric Delabesse, MD, PhD9*, Christian Recher, MD, PhD10* and Hunault-Berger Mathilde11*

1Hematology Department, Angers University Hospital, Angers, France
2Angers University Hospital, ANGERS, AL, FRA
3Laboratoire d’Hématologie Biologique, CHU Bordeaux, Bordeaux, France
4Hôpital Haut-Lévèque, Hematology Department, CHU Bordeaux, Pessac, France
5IUCT-Oncopole, Hematology Department, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
6CHU Angers, Angers, FRA
7Department of Clinical Hematology, Angers University Hospital, ANGERS, NA, France
8University Hospital of Angers, Angers, FRA
9IUCT-Oncopole, Hematology Laboratory, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
10Hematology Department, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
11Angers University Hospital, Angers, France

Bernward Zeller, PhD1*, Nira Arad-Cohen2*, Daniel Cheuk3*, Barbara De Moerloose4*, Jose Maria Fernandez Navarro5*, Henrik Hasle6, Jahnukainen Kirsi7*, Kristian Juul-Dam, MD8*, Gertjan J.L. Kaspers, MD, PhD9,10, Zhanna Kovalova11*, Birgitte Lausen12*, Monica C. Munthe-Kaas13*, Ulrika Norén-Nyström, MD, PhD14*, Josefine Palle15*, Ramune Pasauliene16*, Cornelis Jan Pronk, MD, PhD17*, Kadri Saks18*, Anne Maria Tierens, MD, PhD19 and Jonas Abrahamsson20*

1Department of Pediatric Hematology-Oncology, Oslo University Hospital, Oslo, Norway
2Department of Pediatric Hemato-Oncology, Rambam Health Care Campus, Haifa, Israel;, Haifa, Israel
3Department of Pediatrics and Adolescent Medicine, Hong Kong Children's Hospital, University of Hong Kong, Hong Kong, China
4Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium
5Department of Pediatric Hemato-Oncology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
6Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
7New Children´s hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, Helsinki, Finland
8Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Aarhus, Denmark
9VU University Medical Center, Utrecht, Netherlands
10Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
11Department of Pediatric Oncology/Hematology, Children's Clinical University Hospital, Riga, Latvia
12Department of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Denmark, Copenhagen, Denmark
13Department of Pediatric Oncology, Oslo University Hospital, Oslo, Norway
14Department of Clinical Sciences, Pediatrics, Umea University, Umea, Sweden., Umea, Sweden
15Department of Women´s and Children´s Health, Uppsala University, Uppsala, Sweden, Uppsala, Sweden
16Center for Pediatric Oncology and Hematology, Vilnius University Children’s Hospital, Vilnius, Lithuania
17Childhood Cancer Center, Skåne University Hospital, Lund, Sweden
18Department of Hematology Oncology, Tallinn Children´s Hospital, Tallinn, Estonia
19Laboratory Medicine Program, University Health Network, Toronto, ON, Canada
20Institution for Clinical Sciences, Department of Pediatrics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, Gothenburg, Sweden

Nickolas Steinauer, MD, PhD1, Kristen McCullough, PharmD2, Aref Al-Kali, MD2, Hassan Alkhateeb, MD2*, Kebede Begna, MD2, Abhishek A Mangaonkar, MBBS2, Antoine Saliba, MD2, Mehrdad Hefazi, MD2, Mark R. Litzow, MD2, William J. Hogan, MD2, Mithun V Shah, MD, PhD2, Animesh D. Pardanani, MBBS, PhD2, Talha Badar, MD3, Hemant S. Murthy, MD4, James M. Foran, MD5, Cecilia Y. Arana Yi, MD6, Ayalew Tefferi, MD2 and Naseema Gangat, MBBS2

1Mayo Clinic, Rochester, MN
2Division of Hematology, Mayo Clinic, Rochester, MN
3Mayo Clinic, Jacksonville, FL
4Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
5Hematology/Oncology, Mayo Clinic, Jacksonville, FL
6Hematology/Oncology, Mayo Clinic, Scottsdale, AZ

Sjoerd J.F. Hermans, MD1*, Jurjen Versluis, MD, PhD1*, Yvette van Norden, PhD1,2*, Erik D. van Werkhoven, MSc1,2*, Jeroen J.W.M. Janssen, MD, PhD3, Gerwin A. Huls, Prof.4, Bob Lowenberg, MD, PhD1, Thomas Pabst, MD5, Dimitri A. Breems, MD, PhD6, Elizabeth Berkx, PhD7*, Avinash G. Dinmohamed, PhD7*, Peter C. Huijgens, Prof.7*, Eric Sträng8*, Jesús María Hernández-Rivas, PhD9, Hartmut Döhner, MD10, Marta Sobas, MD, PhD11*, Lars Bullinger12, Rosa Ayala, MD, PhD13*, Joaquin Martinez-Lopez, MD, PhD13*, Klaus H Metzeler, MD14, Torsten Haferlach, MD, PhD15, Christian Thiede, MD16, Carin A. Uyl-De Groot, Prof.17*, Gert J. Ossenkoppele, MD, PhD18, Francesco Pignatti19* and Jan J. Cornelissen, MD, PhD1*

1Erasmus University Medical Center Cancer Institute, Rotterdam, Netherlands
2HOVON Foundation, Rotterdam, Netherlands
3Department of Hematology, University Medical Centre Nijmegen, Nijmegen, Netherlands
4Dept. of Hematology, University Medical Center Groningen (UMCG), Groningen, Netherlands
5Institute of Medical Oncology, Berne, Switzerland
6Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium
7Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, Netherlands
8Department of Hematology, Oncology, Tumor Immunology, Charité University Medicine, Berlin, Germany
9Servicio de Hematología, Hospital Universita­rio de Salamanca, Universidad de Salamanca, Salamanca, Spain
10Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
11Wroclaw Medical University, Wroclaw, Poland
12Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany
13Hematology Department, Hospital 12 de Octubre (i+12), Centro Nacional de Investigaciones Oncológicas (CNIO), Complutense University, Madrid, Spain
14Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Leipzig Medical Center, Leipzig, NA, Germany
15MLL Munich Leukemia Laboratory, Munich, Germany
16Department of Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany
17Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, Netherlands
18Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Vrije Universiteit University Medical Center, Amsterdam, Netherlands
19Oncology and Hematology Office, European Medicines Agency, Amsterdam, Netherlands

Eduardo Magalhães Rego, MD, PhD1, Marcia Higashi, MD2*, Monica Alejandra Romero, MD3*, Alicia I. Enrico, MD4*, Isolda Isabel Fernandez, MD5*, Gustavo Jarchum, MD6*, Sandra Aruachan, MD7*, Guillermo Quintero, MD8*, Alana Vicente, MD9*, Alexander Russell-Smith, MSc10* and Vivian Blunk, MD11*

1Hematology Service, LIM-31 and State of Sao Paulo Cancer Institute, University of São Paulo, Faculdade de Medicina, São Paulo, São Paulo, Brazil
2Hospital Amaral Carvalho, Jau, BRA
3Hematology Division, Hospital Guillermo Grant Benavente, Concepcion, CHL
4Hospital Italiano de La Plata, La Plata, Argentina
5FUNDALEU, Buenos Aires, Argentina
6Sanatorio Allende, Córdoba, Argentina
7IMAT Oncomédica AUNA, Montería, Colombia
8Instituto de Cancerología Carlos Ardila Lulle, Fundación Santa Fé de Bogotá, Bogota, Bogotá Distrito Capital, COL
9Pfizer Brazil, Sao Paulo, Brazil
10Pfizer R&D UK Ltd, Sandwich, GBR
11Pfizer Inc, São Paulo, Brazil

Taegeun Lee1*, Daehyun Chu, M.D.2*, Miyoung Kim, M.D., Ph.D.2*, Young-Uk Cho, M.D., Ph.D.2*, Sang-Hyun Hwang, M.D., Ph.D.2* and Seongsoo Jang, M.D., Ph.D.2

1Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
2Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)

Kriti Gera, MD1*, Daniela Martir, MD2*, Doga Kahramangil3*, Mansi Dalal, MD4 and Bently Doonan, MD, MS5*

1Department of Internal Medicine, University of Florida, GaiNesville, FL
2Department of Internal Medicine, University of Florida College of Medicine, Gainesville, FL
3University of Florida Health Cancer Center, Gainesville, FL
4Department of Pediatric Hematology and Oncology, University of Florida College of Medicine, Gainesville, FL
5Division of Hematology and Oncology, Department of Medicine, University of Florida College of Medicine, Gainesville, FL

Anna Johnson, DO1, Zena Chahine, MD1, Trevor Morris, MD2*, Ashley Soule, PharmD3*, Hiffsa Taj, MBBS1, Claire McAvoy, PharmD3*, Xitong Zhou4*, Chaitanya Iragavarapu, MD1*, Reinhold Munker, MD1, Gregory Monohan, MD1, Reshma Ramlal, MD1, Ayman Qasrawi, MD1* and Fevzi Yalniz, MD1*

1Department of Hematology, University of Kentucky, Lexington, KY
2Department of Internal Medicine, University of Kentucky, Lexington, KY
3Department of Pharmacy Services, University of Kentucky, Lexington, KY
4Translational Oncology Research Department, University of Kentucky, Lexington, KY

Dhruvkumar Gadhiya, MBBS, MD1, Hiren Chhayani2*, Cleris Christian3*, fredy Reynaldo pavon Enamorado4*, Mohammed Dheyaa Marsool Marsool5*, Tirath Patel6* and Hardik Dineshbhai Desai, MBBS7*

1Internal Medicine, St.Luke's University Health- Anderson Campus, Easton, PA
2G.M.E.R.S. Medical College, Gandhinagar, Gujarat, India., Gandhinagar, India
3BJ Medical College, Ahmedabad, India
4Universidad Catolica de Honduras, Tegucigalpa, Honduras
5University of Baghdad, Kindy College of Medicine,, Baghdad, Iraq
6American University of Antigua, Saint John, Antigua and Barbuda, Antigua, Antigua and Barbuda
7Gujarat Adani Institute of Medical Sciences, Affiliated to K.S.K.V University, Bhuj, India, Bhuj, India

Eunice S Wang, MD1, Hongtao Liu, MD, PhD2, Daniel N. Egan, MD3, Adrian Kilcoyne, MD4*, Bhavani Stout, MSc4*, Natalia Ruggeri Barbaro, PhD5*, Cherie Daly6*, Siyara Kilcoyne5*, Robert Hariri, MD, PhD7* and James McCloskey, MD8

1Department of Medicine, Roswell Park Comprehensive Cancer Center, BUFFALO, NY
2University of Wisconsin-Madison, Madison, WI
3Swedish Center for Blood Disorders and Stem Cell Transplants, Seattle, WA
4Celularity, Florham Park, NJ
5Celularity, Florham Park
6Celularity Inc, Warren, NJ
7Celularity, florham park, NJ
8The John Theurer Cancer Center at Hackensack Meridian Health, Hackensack, NJ

Xiaoli Chen1*, Mengxing Xue2*, Qian Wu3*, Yun Wang4*, Ailing Deng4*, Xueqing Dou5*, Yuhua Ru6*, Depei Wu7 and Suning Chen, MD8*

1Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, AL, China
2First Affiliated Hospital of Soochow University, Su Zhou, China
3National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China, Suzhou, China
4First Affiliated Hospital of Soochow University, Suzhou, China
5National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
6The First Affiliated Hospital of Soochow University, Suzhou, CHN
7Department of Hematology, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, China
8Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China

Aditi Vedi, MBBS1,2*, Irum Memon3*, Else Van Risjik4*, Urmila Uparkar4*, Geofffrey Shenton5*, Amélie Trinquand6*, Katherine Clesham, MBBS, FRPATH7*, Vanessa Mclelland8*, Helen Jane Campbell, FRCP, MD, FRCPath9*, Katharine Patrick10*, Lyndsey Thompson11*, Susan Baird12*, Philip Connor13* and Beki James14*

1Paediatric Haematology/Oncology, Cambridge University Hospitals, Cambridge, United Kingdom
2Department of Paediatrics, University of Cambridge, Cambridge, United Kingdom
3Great Ormond Street Hospital, London, United Kingdom
4Royal Marsden Hospital, London, United Kingdom
5Royal Victoria Infirmary, Newcastle Upon Tyne, ENG, GBR
6Children’s Health Ireland (CHI) at Crumlin, Crumlin, D12 N512, Dublin, IRL
7UCL Great Ormond Street Hospital for Children, London, GBR
8University Hospital Bristol, Bristol, United Kingdom
9Astmoore Industrial Estate, Cheshire, GBR
10Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom
11Belfast Hospital, Belfast, United Kingdom
12Royal Hospital for Children and Young People, Edinburgh, United Kingdom
13Children's Hospital For Wales, Cardiff, GBR
14Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom

Michelle Y. Zhang, MD1*, Megan Othus, PhD2,3, Kerry K McMillen, MS, RD, CSO, FAND4*, Harry P. Erba, MD, PhD5, Guillermo Garcia-Manero, MD6, John Pagel, MD, PhD7, Mohamed Sorror, MD, MSc4,8 and Mary-Elizabeth M. Percival, MD4,8

1University of Washington, Seattle, WA
2SWOG Statistics and Data Mangement Center, Seattle, WA
3Public Health Science Division, Fred Hutchinson Cancer Center, Seattle, WA
4Fred Hutchinson Cancer Center, Seattle, WA
5University of Alabama At Birmingham, Durham, NC
6University of Texas MD Anderson Cancer Center, Houston, TX
7Loxo Oncology at Lilly, Stamford, CT
8Department of Medicine, University of Washington, Seattle, WA

Gaspar Aspas Requena, MD1*, Pierre Yves Dumas, MD, PhD2*, Rebeca Rodriguez Veiga, MD3*, Sarah Bertoli4*, Cristina Gil, MD5*, Celestine Simand, MD6*, Fernando Jesús Ramos-Ortega, MD7*, Pierre Peterlin8*, Josefina Serrano, MD9*, Rudy Birsen, MD10*, Teresa Bernal Del Castillo, MD, PhD11*, Emmanuelle Tavernier, MD12*, Mar Tormo, M.D.13, Martin Carre, MD14*, Maria Jose Garcia, MD15*, Adrien Contejean, MD16*, Rosalia Riaza Grau, MD17*, Corentin Orvain18*, Jose Antonio Pérez-Simón19, Esther Perez Santaolla, MD20*, Lauren Veronese, MD21*, Beatriz De Rueda Ciller, MD22*, Eric Delabesse, MD, PhD23*, Antonio Gutiérrez, MD, PhD24*, Ariane Mineur25*, Adolfo De La Fuente Burguera, MD26*, Romain Guieze, MD, PhD27*, Arnaud Pigneux, MD, PhD28*, Pau Montesinos, PhD, MD29*, Christian Recher, MD, PhD30* and David Matínez-Cuadrón, PhD31*

1Hématologie, Centre Hospitalier Universitaire Clermont-Ferrand, Clermont-Ferrand, France
2Department of Clinical Hematology, Bordeaux University Hospital, PESSAC, France
3Hospital Universitary i Politecnic La Fe, VALENCIA, ESP
4IUCT-Oncopole, Hematology Department, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
5Hospital General Universitario de Alicante, Alicante, ESP
6Hematology, Institut de Cancerologie Strasbourg Europe (ICANS), Strasbourg, France
7Hospital Universitario de León, León, Spain
8Hematology Department, Hôpital Hotel Dieu, NANTES CEDEX 1, France
9Hospital Universitario Reina Sofía, IMIBIC, Cordoba, ESP
10Assistance Publique-Hopitaux De Paris, Hopital Cochin, Service D'héMatolo, Paris, FRA
11Hospital Universitario Central de Asturias, Oviedo, Spain
12Département d'hématologie Clinique et de Thérapie Cellulaire, CHU Saint-Etienne, Saint-Etienne, France
13Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain
14Clinical Hematology Department, CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble, France
15Complejo Hospitalario Torrecardenas, ALMERIA, ESP
16Hématologie, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, FRA
17Hospital Universitario Severo Ochoa, Madrid, ESP
18Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Angers, France
19Instituto de Biomedicina de Sevilla (IBIS), Servicio de Hematología, Hospital Universitario Virgen del Rocío and Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Sevilla, Sevilla, Spain
20Hospital Donostia, Donostia, Spain
21Centre Hospitalier Universitaire Clermont-Ferrand, Clermont Ferrrand, FRA
22Hospital Miguel Servet - Zaragoza, Zaragoza, Spain
23University Hospital of Toulouse, University of Toulouse 3, Center of Research On, Toulouse, NA, FRA
24Hematology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain
25Hôpital Haut-Lévèque, FILO Group Coordination, Pessac, France
26MD Anderson Cancer Center, Madrid, ESP
27Centre Hospitalier Universitaire Clermont-Ferrand, Clermont-Ferrand, France
28Hôpital Haut-Lévèque, Hematology Department, CHU Bordeaux, Pessac, France
29Hospital Universitari i Politecnic la Fe, Valencia, Spain
30Hematology Department, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
31Hematology, Instituto de Investigación Sanitaria La Fe, Valencia, Spain

Shai Shimony, MD1,2*, Julia Keating, MS3*, Christopher Fay4*, Marlise R. Luskin, MD5, Donna S. Neuberg, ScD3, Nicole R. Leboeuf4* and Andrew A. Lane, MD, PhD5

1Department of Hematology, Rabin Medical Center, Tel Aviv Faculty of Medicine, Tel Aviv, Israel
2Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
3Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
4Dermatology, Brigham and Women Hospital, Boston, MA
5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Philip A Haddad, MD1 and Shiva Jashwanth Gaddam, MD2

1Feist-Weiller Cancer Center, LSUHSC-S/Overton Brooks VAMC, Shreveport, LA
2Department of Hematology and Oncology and Feist Weiller Cancer Center, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA

Hongming Zhu*, Yubing Zhao*, Wenyan Cheng*, Xinjie Chen*, Yunxiang Zhang*, Jiong Hu, Junmin Li* and Yang Shen*

Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

*signifies non-member of ASH